CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
Related Experiment Video
Updated: Jan 20, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Daniel Long1, Kemar Green2, Talal Derani2
1From the Memorial Institute for Neurosciences and Multiple Sclerosis (D.L., N.D., R.J.P., R.A.); Michigan State University (K.G.); and University of Toledo (T.D.). Daniel.l.long51@gmail.com.
No abstract available in PubMed .
Related Concept Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
11:03Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
13:42Clinical Examination Protocol to Detect Atypical and Classical Scrapie in Sheep
07:47Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
01:30Ultrastructural Analysis of Demyelination in Mouse Spinal Cord Cross-Sections
Antipsychotic Drugs: Typical and Atypical Agents
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
